Publication | Open Access

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia–reperfusion injury

InflammationThrombosisNovel StrategyCardiovascular DiseaseBlood PlateletMedicineHematologyImmunologyKidney Ischemia–reperfusion InjuryEndothelial-platelet MicroenvironmentEndothelial DysfunctionVascular BiologyReperfusion InjuryPharmacologyPlatelet AntagonistIschemic Syndrome